Harmine hydrochloride reduced secondary sphere formation after drug removal in most tested glioblastoma tumor-initiating cell lines. Response depended on cellular context: DYRK1A-negative GBM1 responded weakly, and EGFR-low, high-passage GBM3 was less sensitive. [1]
In a separate human pluripotent stem-cell model, 0.5 µM harmine hydrochloride reduced the PAX6-positive neural-induction readout at day 16. This finding concerns inhibition of neural differentiation under dual-SMAD induction conditions and limits generalization of beneficial effects across neural models. [2]
Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.
Harmine hydrochloride reduces GBM-TIC secondary sphere formation
Cell-based study · Human primary glioblastoma tumor-initiating cell lines GBM1–GBM6 [1]
Pretreatment reduced secondary sphere formation in most lines after drug removal. DYRK1A-negative GBM1 responded weakly; sensitivity correlated with membrane EGFR, and high-passage EGFR-low GBM3 was less sensitive. INDY was a separate comparator, not a combination.
Literature-Reported Treatment Conditions
- Treatment concentration
- 20 µM
- Exposure duration
- 3 days before dissociation/replating without inhibitor
- Vehicle
- Harmine stock in water; INDY stock in DMSO
- Reported limits
- Exact per-line biological replicate counts and control water addition are not explicit in the acquired main text; supplemental methods were not retrieved. No precise bar heights are inferred.
Methods and source locations
Compound reported in the paper: Harmine hydrochloride; Compound label in the paper: harmine
Salt-matched evidence in the stated cellular models; no catalog-lot validation or universal anticancer response inferred.
Figure 6A–B,G–H and caption; associated Results; Methods: Reagents and Statistics
Secondary sphere formation after drug removal: Secondary sphere assay; Figure 6A shows comparisons with control. INDY in Figure 6B provides a distinct pharmacological comparator. Statistics: two-tailed Student t test; graphs mean ± SEM. — Figure 6A–B and caption; Results: Pharmacological inhibition of DYRK1A
Association of harmine response with membrane EGFR: Surface EGFR/response correlation and low- versus high-passage GBM3 comparison. No exact correlation or bar values extracted. — Figure 6G–H and corresponding Results
Harmine hydrochloride inhibits neural induction in human pluripotent cells
Cell-based study · Human HES3 (PAX6-mCherry) pluripotent stem cells undergoing dual-SMAD neural induction [2]
Harmine reduced the PAX6-positive neural-induction readout relative to the DMSO induction control. This is a differentiation endpoint in non-tumor human stem cells, not evidence of neuroprotection.
Literature-Reported Treatment Conditions
- Treatment concentration
- 0.5 µM
- Exposure duration
- Day-16 endpoint; kinase inhibitor supplementation continued during induction and progenitor culture
- Vehicle
- DMSO; 0.15% in each dish
- Co-treatment
- Neural induction background: SB431542 (5 µM) and LDN193189 (100 nM), removed at day 7; this is not harmine monotherapy in uninduced cells.
- Reported limits
- Exact harmine effect size is not extracted from the graph. Figure 3 caption has malformed/reversed significance labels; a precise star-to-P threshold is not adopted.
Methods and source locations
Compound reported in the paper: Harmine hydrochloride; Compound label in the paper: harmine
Salt-matched neural differentiation experiment; do not transfer ID-8-only pluripotency, apoptosis or genetic-rescue findings to harmine.
Figure 3B/caption; Results: Effects of known DYRK1A and GSK3β inhibitors; Methods: compounds, cell lines, neural induction assay
PAX6-positive neural specification relative to DMSO induction control: Flow-cytometric reporter assay; Figure 3B error bars SD. Neural induction methods report 2–3 repeats with three technical replicates per point; paired two-tailed t test with Benjamini–Hochberg multiple-comparison correction, FDR 0.075. — Figure 3B and caption; corresponding Results; Methods Neural induction assay